Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responsesShow More
Nature Medicine pp 1-1; doi:10.1038/s41591-021-01372-z
The publisher has not yet granted permission to display this abstract.
Keywords: Author Correction / dose induces / SARS CoV / ChAdOx1 nCoV / induces multifunctional / vaccine ChAdOx1 / booster dose / multifunctional antibody
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Nature Medicine" .